The Action of Protamine Derivatives and Nitrogen Mustard on the Growth of the Walker 256 Rat Carcinoma
1965

Effects of Protamine Derivatives and Nitrogen Mustard on Walker 256 Rat Carcinoma

Sample size: 251 publication Evidence: moderate

Author Information

Author(s): W. H. H. Garvie

Primary Institution: Royal Marsden Hospital

Hypothesis

Can protamine derivatives enhance the anti-tumor effects of nitrogen mustard on Walker 256 rat carcinoma?

Conclusion

Prolothan G combined with nitrogen mustard showed greater tumor growth inhibition compared to nitrogen mustard alone.

Supporting Evidence

  • Prolothan G at a dose of 80 mg/kg/day in combination with nitrogen mustard resulted in 50% of the animals being tumor-free at the end of the experiment.
  • None of the animals treated with nitrogen mustard alone survived the duration of the experiment.
  • Prolothan G was found to be more effective than prolothan A in inhibiting tumor growth.

Takeaway

This study tested if a special medicine could help another medicine work better against cancer in rats, and it found that one combination worked well.

Methodology

The study involved transplanting Walker 256 carcinoma cells into male Wistar rats and treating them with various combinations of nitrogen mustard and protamine derivatives.

Limitations

The study did not achieve a survival rate greater than 50% at one month with the tested doses.

Participant Demographics

Male Wistar rats, weighing between 160-200 g and approximately 7 weeks old.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication